Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
A Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
Gray matter atrophy in multiple sclerosis: a longitudinal study.
Is progressive multiple sclerosis a gray matter disease?
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
Histologie de la sclerose en plaques
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.
The origin and application of experimental autoimmune encephalomyelitis.
Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Mycophenolate mofetil in multiple sclerosis.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
An Electrophoretic Study of the Protein Components in Cerebrospinal Fluid and their Relationship to the Serum Proteins.
American Medical Association fact sheet on ocrelizumab
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis.
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.